Windtree Therapeutics, Inc. (WINT)
0.0168
0.00 (0.00%)
USD |
OTCM |
Apr 10, 16:00
Windtree Therapeutics EPS Diluted (Quarterly) : -1.085 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| Plus Therapeutics, Inc. | -1.03 |
| Halozyme Therapeutics, Inc. | -1.203 |
| AIM ImmunoTech, Inc. | -1.359 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.08M |
| Total Expenses (Quarterly) | 28.08M |
| Enterprise Value | 13.30M |
| Earnings Yield | -50.66K% |
| Normalized Earnings Yield | -155772.0 |